11:18 PM EDT, 08/04/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) said Tuesday that its net profit and net sales for the first half of 2026 rose year over year. Net profit for the six months ended June 30 was 69.55 billion Danish kroner, compared with 55.54 billion kroner a year ago. EPS moved to 15.66 kroner from 12.49 kroner. The Danish pharmaceutical company's net sales were 175.31 billion kroner, compared with 154.94 billion kroner earlier. Meanwhile, the board resolved to pay an unchanged interim dividend of 3.75 kroner per share for the period, payable on Aug. 18 for class A and B shares, to shareholders on record Aug. 17. For 2026, the company lifted its adjusted sales and operating profit growth guidance to between 0% and -6% at constant exchange rates, compared with -4% to -12% previously.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.